Effect Of Low-intensity Shockwave Therapy Research Articles

The effect of low-intensity shockwave therapy on moderate erectile dysfunction: a double-blind, randomized, placebo-controlled clinical trial

The effect of low-intensity shockwave therapy on moderate erectile dysfunction: a double-blind, randomized, placebo-controlled clinical trial

Low intensity extracorporeal shockwave therapy for chronic pelvic pain syndrome patients with erectile dysfunction.

Introduction:In this study, the efficacy of low intensity shock wave therapy (LSWT) in improving symptoms of chronic pelvic pain syndrome (CPPS) and erectile dysfunction (ED) was investigated.Methods:Men diagnosed with CPPS and ED (n = 50) were prescribed with LSWT. The LSWT was administered in 10 sessions over the course of 5 weeks at 3,000 pulses with .25 mJ/mm2 energy flow and 5 Hz frequency. Outcome parameters were measured before and after LSWT.Results:Clinical symptoms related to CPPS and ED were measured using four validated questionnaires namely National Institute of Health Chronic Prostatitis Symptom Index (NIH-CPSI), the International Index of Erectile Function (IIEF), the International Prostate Symptom Score (IPSS), and Sexual Health Inventory for Men (SHIM). The effect of LSWT on each of the three domains of NIH-CPSI, namely Pain, Symptoms, and Quality of Life (QoL) were also analyzed. Uroflowmetry was measured to assess LSWT effect on urine voiding. The mean baseline CPPS symptoms on NIH-CPSI domains of pain, symptoms and QoL were 9.92 ± 5.72 (mean ± SD), 5.14 ± 14.5, and 8.02 ± 3.17, respectively. LSWT resulted in significant reduction of CPPS symptoms on all NIH-CPSI domains (Pain = .9 ± 1.37; Symptoms = .74 ± 1.03; QoL = 1.16 ± 1.78). The baseline means of CPPS symptoms on IIEF, IPSS, and SHIM were 45.42 ± 16.24, 24.68 ± 9.28, and 14.28 ± 6.02, respectively. LSWT significant improved CPPS symptoms on IIEF (49.48 ± 28.30) and IPSS (9.04 ± 7.01) but not on SHIM (16.02 ± 9.85). No statistically significant differences were observed with all uroflowmetry parameters.Conclusion:The current study demonstrated for the first time the safety and efficacy of LSWT administered in 10 sessions over 5 weeks in improving symptoms of CPPS and ED without causing any significant adverse effect to the patient.

Latest addition to a long LIST of negative penile rehabilitation trials does not come as a shock.

A randomized controlled trial has shown no statistically significant effect of low-intensity shockwave therapy when added to standard postprostatectomy pharmaceutical penile rehabilitation. Although this trial had a number of limitations, it adds to a body of literature that shows little effect of this therapy and emphasizes the need for development of effective therapeutic options for these patients.

1117 - Additive pro-erectile effect of low intensity-shockwave therapy (Li-ESWT) delivered by Aries® combined with sildenafil in spontaneously hypertensive rats (SHR)

1117 - Additive pro-erectile effect of low intensity-shockwave therapy (Li-ESWT) delivered by Aries® combined with sildenafil in spontaneously hypertensive rats (SHR)